<bill session="117" type="s" number="4303" updated="2022-12-29T16:48:34Z">
  <state datetime="2022-05-25">REFERRED</state>
  <status>
    <introduced datetime="2022-05-25"/>
  </status>
  <introduced datetime="2022-05-25"/>
  <titles>
    <title type="display">Interchangeable Biologics Clarity Act</title>
    <title type="short" as="introduced">Interchangeable Biologics Clarity Act</title>
    <title type="official" as="introduced">A bill to provide for a period of exclusivity for first interchangeable biological products.</title>
  </titles>
  <sponsor bioguide_id="K000384"/>
  <cosponsors>
    <cosponsor bioguide_id="C001035" joined="2022-05-25"/>
    <cosponsor bioguide_id="H001076" joined="2022-06-16"/>
  </cosponsors>
  <actions>
    <action datetime="2022-05-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-05-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S2709-2710" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="4348" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:55:01Z" status="Introduced in Senate">Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.</summary>
</bill>
